AI assistant
CVS HEALTH Corp — Director's Dealing 2021
May 12, 2021
29875_dirs_2021-05-12_0e177424-89aa-4d74-a758-5360b1fe13f9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-05-10
Reporting Person: Moriarty Thomas M (EVP & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-10 | Common Stock | M | 109469 | $62.21 | Acquired | 109469 | Direct |
| 2021-05-10 | Common Stock | S | 109469 | $86.00 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-10 | Stock Option | $62.21 | M | 109469 | Disposed | 2025-04-01 | Common Stock (109469) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 81179.0221 | Indirect |
| Common Stock (restricted) | 8008 | Direct |
| Stock Unit | 45747.7872 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $102.26 | 2022-04-01 | Common Stock (51361) | 51361 | Direct |
| Stock Option | $104.82 | 2023-04-01 | Common Stock (71696) | 71696 | Direct |
| Stock Option | $78.05 | 2024-04-03 | Common Stock (125224) | 125224 | Direct |
| Stock Option | $54.19 | 2029-04-01 | Common Stock (101004) | 101004 | Direct |
| Stock Option | $58.34 | 2030-04-01 | Common Stock (147837) | 147837 | Direct |
| Stock Option | $74.30 | 2031-04-01 | Common Stock (155495) | 155495 | Direct |
Footnotes
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F3: Option became exercisable in four equal annual installments, commencing 4/1/2016.
F4: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F5: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7: The number of shares subject to the option were calculated using a 30-day average price.
F8: Option became exercisable in four equal annual installments, commencing 4/1/2021.
F9: Option becomes exercisable in four equal installments, commencing 4/1/2022.